These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing]. Mercier C, Bret P, Bret MC, Queuille E. Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368 [Abstract] [Full Text] [Related]
15. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Raskin S, Katz G, Zislin Z, Knobler HY, Durst R. Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556 [Abstract] [Full Text] [Related]
16. [Clinical effects of clozapine: effect on negative symptoms]. Llorca PM, Lançon C, Auquier P, Bougerol T. Encephale; 1996 Apr; 22(4):287-92. PubMed ID: 9035984 [Abstract] [Full Text] [Related]
17. [Clozapine (Leponex) in France]. Péré JJ, Chaumet-Riffaud PD, Bourdeix I, Bourdain M. Encephale; 1992 Sep; 18 Spec No 3():427-32. PubMed ID: 1339758 [Abstract] [Full Text] [Related]
18. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Zink M, Kuwilsky A, Krumm B, Dressing H. J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423 [Abstract] [Full Text] [Related]
19. The efficacy, safety, and tolerability of antipsychotics in the elderly. Maixner SM, Mellow AM, Tandon R. J Clin Psychiatry; 1999 May; 60 Suppl 8():29-41. PubMed ID: 10335669 [Abstract] [Full Text] [Related]